PREDILIFE Logo

PREDILIFE

AI-driven predictive tests assessing cancer and cardiovascular disease risks for partners.

ALPRE | PA

Overview

Corporate Details

ISIN(s):
FR0010169920 (+5 more)
LEI:
9695006IK5NBKHQU9116
Country:
France
Address:
39 RUE CAMILLE DESMOULINS, 94800 VILLEJUIF
Sector:
Human health and social work activities
Industry:
Other human health activities

Description

PREDILIFE is a medical technology company specializing in predictive medicine. Founded in 2004, the company designs and markets predictive tests that assess an individual's risk of developing serious diseases. By combining artificial intelligence and big data with proven medical technologies, PREDILIFE creates personalized risk profiles. Its primary services include the Predictive Check-Up for Breast Cancer (MammoRisk®) and a comprehensive Predictive Check-Up for Multiple Conditions, which covers various cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. The company provides an end-to-end, digital solution for businesses, insurance companies, and healthcare professionals, aiming to make personalized, preventive care more accessible and affordable.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PREDILIFE and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-22 19:00
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UN PLACEMENT PRIVE DE 300 K EUR PERMETTANT D…
French 498.0 KB
2025-06-11 19:00
Capital/Financing Update
Avenant au contrat de liquidité conclu avec TSAF
French 164.0 KB
2025-06-06 20:15
Report Publication Announcement
Mise à disposition du rapport financier annuel 2024
French 383.3 KB
2025-05-15 08:00
Earnings Release
RÉSULTATS ANNUELS 2024 - PERSPECTIVES DE CROISSANCE ET DE PARTENARIAT 2025
French 283.1 KB
2025-04-30 18:30
Report Publication Announcement
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS 2024 ET DU RAPPORT FINANCIER ANN…
French 162.4 KB
2025-01-17 18:00
Regulatory News Service
Bilan semestriel au 31/12/2024 du contrat de liquidité PREDILIFE
French 417.3 KB
2025-01-08 18:30
Earnings Release
PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE P…
French 248.6 KB
2024-12-17 20:00
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE …
French 396.7 KB
2024-11-12 08:30
Capital/Financing Update
Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an s…
French 898.9 KB
2024-11-07 18:30
M&A Activity
Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 …
French 225.6 KB
2024-10-30 19:00
Report Publication Announcement
Predilife met à disposition son rapport financier semestriel 2024
French 158.4 KB
2024-10-28 08:30
Earnings Release
Résultats semestriels 2024 - Perspectives de croissance 2024
French 256.4 KB
2024-10-21 18:30
Environmental & Social Information
Le Groupe Rocher prend une initiative majeure pour la santé des femmes et propo…
French 236.4 KB
2024-10-02 20:30
M&A Activity
Signature du traité d'apport partiel d'actif relatif à la filialisation de Mamm…
French 707.6 KB
2024-07-19 18:00
Regulatory News Service
Bilan semestriel au 30/06/2024 du contrat de liquidité PREDILIFE
French 797.7 KB

Automate Your Workflow. Get a real-time feed of all PREDILIFE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PREDILIFE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-30 N/A Other Buy 200 960.00 EUR
2024-07-04 N/A Other Buy 400 2,720.00 EUR
2024-06-26 N/A Other Buy 2,000 12,000.00 EUR
2024-06-18 N/A Other Buy 500 2,800.00 EUR
2024-05-02 N/A Other Sell 8,500 204,000.00 EUR
2024-04-26 N/A Other Buy 599 2,635.60 EUR
2024-02-28 N/A Other Buy 1,600 6,720.00 EUR
2024-02-26 N/A Other Buy 500 2,150.00 EUR
2024-02-22 N/A Other Buy 500 2,250.00 EUR
2024-02-20 N/A Other Other 1,000 4,800.00 EUR

Peer Companies

Company Country Ticker View
Center for Genetics and Reproductive Medicine "GENETICO" Logo
Advanced genetic testing for reproductive health, prenatal screening, and oncogenetics.
Russian Federation GECO
Debarski Banji Capa AD Logo
Offers medical rehab and spa wellness using unique thermo-mineral waters.
North Macedonia DEBA
Diagnostyka SA Logo
Poland's largest medical lab network offering over 4,000 routine and specialist diagnostic tests.
Poland DIAG
Develops digital diagnostic tests for healthcare pros, enabling personalized disease treatment.
United Kingdom N/A
Genomed Spolka Akcyjna Logo
Offers molecular diagnostics and DNA sequencing for medical and scientific research markets.
Poland GEN
iDNA Genomics Public Ltd Logo
Provides AI-driven DNA tests for personalized health, wellness, and medication insights.
Cyprus IDNA
Imalliance Logo
A French medical imaging network offering radiology, MRI, and scans to patients and professionals.
France MLIML
IMCB PJSC Logo
Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.
Russian Federation GEMA
Immunovia Logo
Develops blood tests for early pancreatic cancer detection in high-risk individuals.
Sweden IMMNOV
Inify Laboratories AB Logo
AI-powered digital pathology lab providing fast cancer diagnostics for healthcare providers.
Sweden INIFY

Talk to a Data Expert

Have a question? We'll get back to you promptly.